Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ)
CNY 21.47
(3.02%)
CNY 21.47
(3.02%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.18 Billion CNY | 6.59% |
| 2022 | 1 Billion CNY | 8.38% |
| 2021 | 925.86 Million CNY | 8.14% |
| 2020 | 856.13 Million CNY | 11.07% |
| 2019 | 770.8 Million CNY | 26.38% |
| 2018 | 609.89 Million CNY | 36.77% |
| 2017 | 445.93 Million CNY | 29.53% |
| 2016 | 344.25 Million CNY | 17.14% |
| 2015 | 293.89 Million CNY | 13.26% |
| 2014 | 259.47 Million CNY | 27.72% |
| 2013 | 203.16 Million CNY | 23.96% |
| 2012 | 163.9 Million CNY | 38.13% |
| 2011 | 118.65 Million CNY | 36.3% |
| 2010 | 87.05 Million CNY | 39.12% |
| 2009 | 62.57 Million CNY | 31.41% |
| 2008 | 47.61 Million CNY | 40.47% |
| 2007 | 33.89 Million CNY | 110.09% |
| 2006 | 16.13 Million CNY | 14.87% |
| 2005 | 14.04 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | 413 Million CNY | 45.28% |
| 2024 Q3 | 438.83 Million CNY | 6.26% |
| 2024 Q1 | 284.28 Million CNY | 161.93% |
| 2023 Q1 | 261.57 Million CNY | 69.22% |
| 2023 FY | 1.06 Billion CNY | 6.59% |
| 2023 Q4 | 108.53 Million CNY | -71.39% |
| 2023 Q3 | 379.36 Million CNY | 4.07% |
| 2023 Q2 | 364.51 Million CNY | 39.35% |
| 2022 FY | 1 Billion CNY | 8.38% |
| 2022 Q3 | 334.25 Million CNY | 9.62% |
| 2022 Q2 | 304.93 Million CNY | 45.42% |
| 2022 Q1 | 209.69 Million CNY | 44.44% |
| 2022 Q4 | 154.57 Million CNY | -53.75% |
| 2021 Q3 | 295.98 Million CNY | 1.51% |
| 2021 FY | 925.86 Million CNY | 8.14% |
| 2021 Q1 | 193.13 Million CNY | 2.68% |
| 2021 Q2 | 291.57 Million CNY | 50.97% |
| 2021 Q4 | 145.17 Million CNY | -50.95% |
| 2020 Q4 | 188.1 Million CNY | -27.27% |
| 2020 FY | 856.13 Million CNY | 11.07% |
| 2020 Q1 | 159.35 Million CNY | -5.19% |
| 2020 Q3 | 258.63 Million CNY | 3.43% |
| 2020 Q2 | 250.05 Million CNY | 56.92% |
| 2019 Q2 | 230.66 Million CNY | 59.9% |
| 2019 Q3 | 227.81 Million CNY | -1.24% |
| 2019 FY | 770.8 Million CNY | 26.38% |
| 2019 Q1 | 144.25 Million CNY | 15.42% |
| 2019 Q4 | 168.06 Million CNY | -26.23% |
| 2018 Q2 | 182.35 Million CNY | 55.01% |
| 2018 FY | 609.89 Million CNY | 36.77% |
| 2018 Q4 | 124.98 Million CNY | -32.4% |
| 2018 Q1 | 117.64 Million CNY | 113.81% |
| 2018 Q3 | 184.9 Million CNY | 1.4% |
| 2017 Q3 | 157.06 Million CNY | 12.45% |
| 2017 Q1 | 94.16 Million CNY | 90.97% |
| 2017 FY | 445.93 Million CNY | 29.53% |
| 2017 Q4 | 55.02 Million CNY | -64.97% |
| 2017 Q2 | 139.67 Million CNY | 48.33% |
| 2016 Q3 | 94.41 Million CNY | -20.21% |
| 2016 FY | 344.25 Million CNY | 17.14% |
| 2016 Q1 | 82.19 Million CNY | 100.79% |
| 2016 Q4 | 49.3 Million CNY | -47.78% |
| 2016 Q2 | 118.32 Million CNY | 43.95% |
| 2015 Q3 | 81.3 Million CNY | -20.02% |
| 2015 Q2 | 101.65 Million CNY | 45.22% |
| 2015 FY | 293.89 Million CNY | 13.26% |
| 2015 Q1 | 69.99 Million CNY | 59.33% |
| 2015 Q4 | 40.93 Million CNY | -49.65% |
| 2014 Q4 | 43.93 Million CNY | -36.58% |
| 2014 FY | 259.47 Million CNY | 27.72% |
| 2014 Q3 | 69.27 Million CNY | -22.85% |
| 2014 Q2 | 89.78 Million CNY | 58.97% |
| 2014 Q1 | 56.48 Million CNY | 70.99% |
| 2013 Q2 | 70.48 Million CNY | 58.67% |
| 2013 Q3 | 55.23 Million CNY | -21.64% |
| 2013 Q4 | 33.03 Million CNY | -40.19% |
| 2013 FY | 203.16 Million CNY | 23.96% |
| 2013 Q1 | 44.41 Million CNY | 62.11% |
| 2012 Q3 | 46.51 Million CNY | -16.54% |
| 2012 FY | 163.9 Million CNY | 38.13% |
| 2012 Q4 | 27.4 Million CNY | -41.09% |
| 2012 Q1 | 34.25 Million CNY | 118.84% |
| 2012 Q2 | 55.73 Million CNY | 62.71% |
| 2011 Q1 | 24.98 Million CNY | 87.93% |
| 2011 FY | 118.65 Million CNY | 36.3% |
| 2011 Q3 | 36.33 Million CNY | -12.81% |
| 2011 Q4 | 15.65 Million CNY | -56.93% |
| 2011 Q2 | 41.67 Million CNY | 66.77% |
| 2010 Q4 | 13.29 Million CNY | -47.16% |
| 2010 FY | 87.05 Million CNY | 39.12% |
| 2010 Q3 | 25.16 Million CNY | -15.1% |
| 2010 Q2 | 29.64 Million CNY | 56.38% |
| 2010 Q1 | 18.95 Million CNY | 75.15% |
| 2009 Q4 | 10.82 Million CNY | -36.75% |
| 2009 FY | 62.57 Million CNY | 31.41% |
| 2009 Q1 | 13.01 Million CNY | 80.0% |
| 2009 Q3 | 17.11 Million CNY | -20.87% |
| 2009 Q2 | 21.62 Million CNY | 66.09% |
| 2008 Q4 | 7.23 Million CNY | -46.42% |
| 2008 Q3 | 13.5 Million CNY | -20.28% |
| 2008 Q2 | 16.93 Million CNY | 70.19% |
| 2008 Q1 | 9.94 Million CNY | 108.72% |
| 2008 FY | 47.61 Million CNY | 40.47% |
| 2007 Q3 | 10.84 Million CNY | 0.0% |
| 2007 Q4 | 4.76 Million CNY | -56.04% |
| 2007 FY | 33.89 Million CNY | 110.09% |
| 2006 FY | 16.13 Million CNY | 14.87% |
| 2005 FY | 14.04 Million CNY | 0.0% |